Looking to expand your partner network with the latest in the field of genomics? Consider joining Inpart's global network for free.
Podcast 7 Feb 2025
Targeting the dark genome to develop new therapies to fight obesity
This week, our podcast guest is Samir Ounzain, CEO of Haya Therapeutics. Ounzain was one of the first researchers to publish on lncRNA, also known as the ‘dark genome.’